Crossmark

Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles

Crossref DOI link: https://doi.org/10.4110/in.2017.17.6.378

Published Print: 2017

Update policy: https://doi.org/10.4110/crossmark_policy

Authors

Cho, Ju Hwan
License Information

Text and Data Mining valid from 2017-01-01
More Information

Full text available at:

Synapse: https://synapse.koreamed.org/DOIx.php?id=10.4110/in.2017.17.6.378

the Journal: https://immunenetwork.org/DOIx.php?id=10.4110/in.2017.17.6.378

Publication History

Received: 2017-08-31

Revised: 2017-11-10

Accepted: 2017-11-14

Published online: 2017-11-24

Copyright and Licensing

Copyright: Copyright © 2017. The Korean Association of Immunologists

License: This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.